Business
Featured
Mergers and Acquisitions
News This Week
PMI to Record £220 Million Loss on Vectura Sale
Citing ‘unwarranted opposition,’ the multinational sold the firm for about a third of the purchase price.Read More
Tags :Vectura
'Unwarranted opposition' to the firm’s transformation has negatively impacted the pharmaceutical company’s business, says PMI.Read More
PMI wants a partner to grow and operate Vectura's drug manufacturing outsourcing. Read More
The firm's foray into pharma is proving more challenging than anticipated. Read More
The industry’s move into pharma may be positive for public health. Read More
Nearly half would consider switching inhalers, survey finds.Read More
The company's CEO and CFO have resigned following PMI’s controversial takeover. Read More
Respiratory societies tighten author restrictions after PMI's Vectura acquisition. Read More
The Drug Delivery to the Lungs conference has terminated Vectura’s sponsorship.Read More
The company has acquired or received valid acceptances for 74.77 percent shares in Vectura.Read More
